droxidopa has been researched along with Nervous System Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biaggioni, I; Feirtag, M; Freeman, R; Hewitt, LA; Kaufmann, H; Low, P; Mathias, CJ; Mauney, J; Pedder, S | 1 |
| François, C; Hauser, RA; Hewitt, LA; Rowse, GJ; Vo, P | 1 |
| Hayashi, A; Higa, S; Nakajima, A; Sakoda, S; Suzuki, T; Takaba, Y; Tsuge, I; Yamamura, Y | 1 |
| Hayashi, A; Higa, S; Nakajima, A; Sakoda, S; Suzuki, T; Takaba, Y; Ueji, M | 1 |
| Azuma, T; Hiraga, T; Kishimoto, S; Kobayashi, T; Matsubara, T; Mizuno, R; Sakoda, S; Suzuki, T; Tsujino, S; Yoshida, S | 1 |
| Azuma, T; Ichikawa, K; Kishimoto, S; Mizuno, R; Mizuta, E; Suzuki, T; Tsujino, S | 1 |
2 trial(s) available for droxidopa and Nervous System Disorders
| Article | Year |
|---|---|
Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial.
Topics: Aged; Autonomic Agents; Autonomic Nervous System Diseases; Blood Pressure; Dizziness; Double-Blind Method; Droxidopa; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Multiple System Atrophy; Nervous System Diseases; Parkinson Disease; Posture; Pure Autonomic Failure; Time Factors; Treatment Outcome | 2014 |
Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Droxidopa; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Nervous System Diseases; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic | 2016 |
4 other study(ies) available for droxidopa and Nervous System Disorders
| Article | Year |
|---|---|
Effect of infused L-threo-3,4-dihydroxyphenylserine on adrenergic activity in patients with familial amyloid polyneuropathy.
Topics: Adult; Amyloidosis; Autonomic Nervous System; Blood Pressure; Dopamine beta-Hydroxylase; Droxidopa; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Nervous System Diseases; Norepinephrine; Octopamine; Pulse; Serine; Stereoisomerism; Sympathetic Nervous System | 1980 |
Pharmacokinetic studies of oral L-threo-3,4-dihydroxyphenylserine in normal subjects and patients with familial amyloid polyneuropathy.
Topics: Adult; Amyloidosis; Blood Pressure; Dopamine beta-Hydroxylase; Droxidopa; Female; Humans; Intestinal Absorption; Kinetics; Male; Metanephrine; Middle Aged; Nervous System Diseases; Norepinephrine; Normetanephrine; Serine; Time Factors | 1982 |
Effect of long-term L-threo-3,4-dihydroxyphenylserine administration on alpha 2-adrenergic receptors in platelet membranes in neurologic disorders.
Topics: Aged; Amyloidosis; Benserazide; Blood Platelets; Dose-Response Relationship, Drug; Droxidopa; Drug Therapy, Combination; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Muscular Atrophy; Nervous System Diseases; Neurologic Examination; Norepinephrine; Parkinson Disease; Polyneuropathies; Receptors, Adrenergic, alpha; Yohimbine | 1991 |
Studies of neurocirculatory effects of long-term L-threo-3,4-dihydroxyphenylserine administration in a patient with familial amyloidotic polyneuropathy.
Topics: Amyloidosis; Blood Circulation; Blood Pressure; Consciousness; Droxidopa; Female; Heart Rate; Humans; Hypotension, Orthostatic; Middle Aged; Nervous System; Nervous System Diseases; Serine | 1988 |